Literature DB >> 12692207

Identification of amino acids that are critical to the processivity function of respiratory syncytial virus M2-1 protein.

Helen Zhou1, Xing Cheng, Hong Jin.   

Abstract

The M2-1 protein of respiratory syncytial virus (RSV) is a transcription processivity factor that is essential for virus replication. The function of RSV M2-1 protein can be examined by using an RSVlacZ minigenome assay in vitro since the expression of the lacZ gene is dependent on M2-1. The M2-1 protein of pneumonia virus of mice (PVM), also a member of the Pneumovirus genus, functions poorly in the RSVlacZ minigenome assay despite conservation of the Cys(3)-His(1) motif at its N terminus and an overall 40% amino acid identity with RSV M2-1. To identify the amino acids responsible for the differences between these two proteins, two chimeric proteins were constructed. The RSV/PVM (RP) M2-1 chimera that contains the N-terminal 30 amino acids from RSV and the remaining C-terminal 148 amino acids from PVM maintained a level of activity at an ca. 36% of RSV M2-1. However, the PVM/RSV (PR) M2-1 chimera with the N-terminal 29 amino acids from PVM and 164 amino acids from RSV had an activity of <5% of RSV M2-1, indicating that the functional determinants are mainly located in the N terminus of M2-1. Mutagenesis of the N terminus of PR M2-1 and RSV M2-1 identified that Leu-16 and Asn-17 of RSV M2-1 are critical to the M2-1 function. In addition, several charged residues in the N terminus of RSV M2-1 also contributed to the functional integrity of M2-1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12692207      PMCID: PMC153968          DOI: 10.1128/jvi.77.9.5046-5053.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Respiratory syncytial virus M2-1 protein requires phosphorylation for efficient function and binds viral RNA during infection.

Authors:  T L Cartee; G W Wertz
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

2.  Fidelity of leader and trailer sequence usage by the respiratory syncytial virus and avian pneumovirus replication complexes.

Authors:  A C Marriott; J M Smith; A J Easton
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

3.  Requirement of cysteines and length of the human respiratory syncytial virus M2-1 protein for protein function and virus viability.

Authors:  R S Tang; N Nguyen; X Cheng; H Jin
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells.

Authors:  L S Wyatt; B Moss; S Rozenblatt
Journal:  Virology       Date:  1995-06-20       Impact factor: 3.616

5.  Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus.

Authors:  P L Collins; M G Hill; J Cristina; H Grosfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

6.  Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase.

Authors:  G Sutter; M Ohlmann; V Erfle
Journal:  FEBS Lett       Date:  1995-08-28       Impact factor: 4.124

7.  Effects of mutations in the gene-start and gene-end sequence motifs on transcription of monocistronic and dicistronic minigenomes of respiratory syncytial virus.

Authors:  L Kuo; H Grosfeld; J Cristina; M G Hill; P L Collins
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

8.  Recombinant human respiratory syncytial virus (RSV) from cDNA and construction of subgroup A and B chimeric RSV.

Authors:  H Jin; D Clarke; H Z Zhou; X Cheng; K Coelingh; M Bryant; S Li
Journal:  Virology       Date:  1998-11-10       Impact factor: 3.616

9.  The product of the respiratory syncytial virus M2 gene ORF1 enhances readthrough of intergenic junctions during viral transcription.

Authors:  R W Hardy; G W Wertz
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

10.  Diverse gene junctions of respiratory syncytial virus modulate the efficiency of transcription termination and respond differently to M2-mediated antitermination.

Authors:  R W Hardy; S B Harmon; G W Wertz
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more
  6 in total

1.  Zinc binding activity of human metapneumovirus M2-1 protein is indispensable for viral replication and pathogenesis in vivo.

Authors:  Hui Cai; Yu Zhang; Yuanmei Ma; Jing Sun; Xueya Liang; Jianrong Li
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

2.  The respiratory syncytial virus M2-1 protein forms tetramers and interacts with RNA and P in a competitive manner.

Authors:  Thi-Lan Tran; Nathalie Castagné; Virginie Dubosclard; Sylvie Noinville; Emmanuelle Koch; Mohammed Moudjou; Céline Henry; Julie Bernard; Robert Paul Yeo; Jean-François Eléouët
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

3.  Phosphorylation of Human Metapneumovirus M2-1 Protein Upregulates Viral Replication and Pathogenesis.

Authors:  Hui Cai; Yu Zhang; Mijia Lu; Xueya Liang; Ryan Jennings; Stefan Niewiesk; Jianrong Li
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

4.  Structure and functional analysis of the RNA- and viral phosphoprotein-binding domain of respiratory syncytial virus M2-1 protein.

Authors:  Marie-Lise Blondot; Virginie Dubosclard; Jenna Fix; Safa Lassoued; Magali Aumont-Nicaise; François Bontems; Jean-François Eléouët; Christina Sizun
Journal:  PLoS Pathog       Date:  2012-05-31       Impact factor: 6.823

5.  Drastic changes in conformational dynamics of the antiterminator M2-1 regulate transcription efficiency in Pneumovirinae.

Authors:  Cedric Leyrat; Max Renner; Karl Harlos; Juha T Huiskonen; Jonathan M Grimes
Journal:  Elife       Date:  2014-05-19       Impact factor: 8.140

6.  Identification of functional domains of phosphoproteins of two morbilliviruses using chimeric proteins.

Authors:  Paramananda Saikia; M S Shaila
Journal:  Virus Genes       Date:  2008-04-22       Impact factor: 2.198

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.